Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
NCT04797286Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Sep 2021
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in scleroderma, sponsored by Johns Hopkins University. Started Sep 2021; status: recruiting.
02
Drugs
ASP-001
03
Conditions
scleroderma
Beyond the preview
Go deeper on NCT04797286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04797286.